Oral cavity cancers (OCCs) and oropharyngeal cancers (OPCs) continue to be a major source of morbidity and mortality worldwide requiring the shared effort of numerous specialists. Tobacco and alcohol consumption have long been identified as risk factors for both OCC and OPC. In addition, human papilloma virus (HPV) is gaining its position as the main causal agent for OPC.
Objective
The objective of this study is to analyze the epidemiology of OCC and OPC in Canada.
Methods
Data pertaining to the year of diagnosis, the patient’s sex, age at the time of diagnosis, province/territory, city and postal code of oral cavity, and oropharyngeal malignancies diagnosed during 1992-2010 were extracted from the Canadian Cancer Registry and Le Registre Québécois du Cancer.
Results
In total, 21 685 OCC cases and 15 965 OPC cases were identified from 1992 to 2010. Of those, 84.97% were oral cavity squamous cell carcinomas (SCCs), 88.10% were oropharyngeal SCCs, and both had a significant male predominance. While oral cavity SCC incidence stabilized over the study period, oropharyngeal SCC continued to increase. Oral cavity SCC incidence increased with age, while oropharyngeal SCC incidence peaked in the 50- to 59-year age group. Detailed geographic distribution analysis of patients at the provincial/territorial, city, and postal code levels identified several patient clusters.
Conclusions
This work highlights important epidemiological differences in trends between oral and oropharyngeal cancers, identifies high-incidence postal codes for each malignancy, and correlates incidence/mortality with known risk factors including alcohol/tobacco use and HPV infections, therefore providing a comprehensive understanding of epidemiology for these cancers in Canada.
ChiAC.DayTA.NevilleBW. Oral cavity and oropharyngeal squamous cell carcinoma--an update. CA Cancer J Clin. 2015;65(5):401-421.doi:10.3322/caac.21293
2.
DeschlerDG.RichmonJD.KhariwalaSS.FerrisRL.WangMB. The "new" head and neck cancer patient-young, nonsmoker, nondrinker, and HPV positive: evaluation. Otolaryngol Head Neck Surg. 2014;151(3):375-380.doi:10.1177/0194599814538605
3.
GoldsteinBY.ChangS-C.HashibeM.La VecchiaC.ZhangZ-F. Alcohol consumption and cancers of the oral cavity and pharynx from 1988 to 2009: an update. Eur J Cancer Prev. 2010;19(6):431-465.doi:10.1097/CEJ.0b013e32833d936d
4.
MaaslandDHE.van den BrandtPA.KremerB.GoldbohmRAS.SchoutenLJ. Alcohol consumption, cigarette smoking and the risk of subtypes of head-neck cancer: results from the Netherlands cohort study. BMC Cancer. 2014;14:187.doi:10.1186/1471-2407-14-187
5.
SmithEM.RubensteinLM.HaugenTH.HamsikovaE.TurekLP. Tobacco and alcohol use increases the risk of both HPV-associated and HPV-independent head and neck cancers. Cancer Causes Control. 2010;21(9):1369-1378.doi:10.1007/s10552-010-9564-z
6.
GillisonML.LowyDR. A causal role for human papillomavirus in head and neck cancer. Lancet. 2004;363(9420):1488-1489.doi:10.1016/S0140-6736(04)16194-1
7.
WeatherspoonDJ.ChattopadhyayA.BoroumandS.GarciaI. Oral cavity and oropharyngeal cancer incidence trends and disparities in the United States: 2000-2010. Cancer Epidemiol. 2015;39(4):497-504.doi:10.1016/j.canep.2015.04.007
8.
AuluckA.HislopG.BajdikC.PohC.ZhangL.RosinM. Trends in oropharyngeal and oral cavity cancer incidence of human papillomavirus (HPV)-related and HPV-unrelated sites in a multicultural population: the British Columbia experience. Cancer. 2010;116(11):2635-2644.doi:10.1002/cncr.25087
9.
MifsudM.EskanderA.IrishJet al. Evolving trends in head and neck cancer epidemiology: Ontario, Canada 1993-2010. Head Neck. 2017;39(9):1770-1778.doi:10.1002/hed.24829
10.
WalkerBB.SchuurmanN.AuluckA.LearSA.RosinM. Suburbanisation of oral cavity cancers: evidence from a geographically-explicit observational study of incidence trends in British Columbia, Canada, 1981-2010. BMC Public Health. 2015;15:758-758.doi:10.1186/s12889-015-2111-9
11.
AmarL.LeM.GhazawiFMet al. Prevalence of human T cell lymphotropic virus 1 infection in Canada. Curr Oncol. 2019;26(1):e3-e5.doi:10.3747/co.26.4593
12.
CattelanL.GhazawiFM.LeMet al. Epidemiologic trends and geographic distribution of esophageal cancer in Canada: a national population-based study. Cancer Med. 2020;9(1):401-417.doi:10.1002/cam4.2700
13.
DarwichR.GhazawiFM.RahmeEet al. Retinoblastoma incidence trends in Canada: a national comprehensive population-based study. J Pediatr Ophthalmol Strabismus. 2019;56(2):124-130.doi:10.3928/01913913-20190128-02
14.
DarwichR.GhazawiFM.RahmeEet al. Epidemiology of ophthalmic lymphoma in Canada during 1992-2010. Br J Ophthalmol. 2019;bjophthalmol-2019-314653.doi:10.1136/bjophthalmol-2019-314653
15.
GhazawiFM.AlghazawiN.LeMet al. Environmental and other extrinsic risk factors contributing to the pathogenesis of cutaneous T cell lymphoma (CTCL. Front Oncol. 2019;9:300.doi:10.3389/fonc.2019.00300
16.
GhazawiFM.CyrJ.DarwichRet al. Cutaneous malignant melanoma incidence and mortality trends in Canada: a comprehensive population-based study. J Am Acad Dermatol. 2019;80(2):448-459.doi:10.1016/j.jaad.2018.07.041
17.
GhazawiFM.DarwichR.LeMet al. Incidence trends of conjunctival malignant melanoma in Canada. Br J Ophthalmol. 2020;104(1):23-25.doi:10.1136/bjophthalmol-2019-313977
18.
GhazawiFM.DarwichR.LeMet al. Uveal melanoma incidence trends in Canada: a national comprehensive population-based study. Br J Ophthalmol. 2019;103(12):1872-1876.doi:10.1136/bjophthalmol-2018-312966
19.
GhazawiFM.LeM.AlghazawiNet al. Trends in incidence of cutaneous malignant melanoma in Canada: 1992-2010 versus 2011-2015. J Am Acad Dermatol. 2019;80(4):1157-1159.doi:10.1016/j.jaad.2018.10.055
20.
GhazawiFM.LeM.CyrJet al. Analysis of acute myeloid leukemia incidence and geographic distribution in Canada from 1992 to 2010 reveals disease clusters in Sarnia and other industrial US border cities in Ontario. Cancer. 2019;125(11):1886-1897.doi:10.1002/cncr.32034
21.
GhazawiFM.LeM.LagacéFet al. Incidence, mortality, and spatiotemporal distribution of cutaneous malignant melanoma cases across Canada. J Cutan Med Surg. 2019;23(4):394-412.doi:10.1177/1203475419852048
22.
GhazawiFM.LitvinovIV. Distribution and clustering of cutaneous T-cell lymphoma (CTCL) cases in Canada: a response to a letter. J Cutan Med Surg. 2018;22(6):657-658.doi:10.1177/1203475418786215
23.
GhazawiFM.NetchiporoukE.RahmeEet al. Comprehensive analysis of cutaneous T-cell lymphoma (CTCL) incidence and mortality in Canada reveals changing trends and geographic clustering for this malignancy. Cancer. 2017;123(18):3550-3567.doi:10.1002/cncr.30758
24.
GhazawiFM.NetchiporoukE.RahmeEet al. Distribution and clustering of cutaneous T-cell lymphoma (CTCL) cases in Canada during 1992 to 2010. J Cutan Med Surg. 2018;22(2):154-165.doi:10.1177/1203475417745825
25.
LagacéF.GhazawiFM.LeMet al. Analysis of incidence, mortality trends, and geographic distribution of breast cancer patients in Canada. Breast Cancer Res Treat. 2019;178(3):683-691.doi:10.1007/s10549-019-05418-2
26.
LagacéF.GhazawiFM.LeMet al. Penile invasive squamous cell carcinoma: analysis of incidence, mortality trends, and geographic distribution in Canada. J Cutan Med Surg. 2019;120347541988886.doi:10.1177/1203475419888869
27.
LeM.GhazawiFM.AlakelAet al. Incidence and mortality trends and geographic patterns of follicular lymphoma in Canada. Curr Oncol. 2019;26(4):e473-e481.doi:10.3747/co.26.4625
28.
LeM.GhazawiFM.RahmeEet al. Identification of significant geographic clustering of polycythemia vera cases in Montreal, Canada. Cancer. 2019;125(22):3953-3959.doi:10.1002/cncr.32417
29.
LefrançoisP.TetzlaffMT.MoreauLet al. TruSeq-Based gene expression analysis of formalin-fixed paraffin-embedded (FFPE) cutaneous T-cell lymphoma samples: subgroup analysis results and elucidation of biases from FFPE sample processing on the TruSeq platform. Front Med. 2017;4:153.doi:10.3389/fmed.2017.00153
30.
LefrançoisP.XieP.WangLet al. Gene expression profiling and immune cell-type deconvolution highlight robust disease progression and survival markers in multiple cohorts of CTCL patients. Oncoimmunology. 2018;7(8):e1467856.doi:10.1080/2162402X.2018.1467856
31.
LitvinovIV.TetzlaffMT.RahmeEet al. Identification of geographic clustering and regions spared by cutaneous T-cell lymphoma in Texas using 2 distinct cancer registries. Cancer. 2015;121(12):1993-2003.doi:10.1002/cncr.29301
32.
LitvinovIV.TetzlaffMT.RahmeEet al. Demographic patterns of cutaneous T-cell lymphoma incidence in Texas based on two different cancer registries. Cancer Med. 2015;4(9):1440-1447.doi:10.1002/cam4.472
33.
Litvinov IVTMT.TetzlaffMT.ThibaultPet al. Gene expression analysis in cutaneous T-cell lymphomas (CTCL) highlights disease heterogeneity and potential diagnostic and prognostic indicators. Oncoimmunology. 2017;6(5):e1306618.doi:10.1080/2162402X.2017.1306618
34.
TsangM.LeM.GhazawiFMet al. Multiple myeloma epidemiology and patient geographic distribution in Canada: a population study. Cancer. 2019;125(14):2435-2444.doi:10.1002/cncr.32128
35.
GuptaN.GuptaR.AcharyaAKet al. Changing Trends in oral cancer - a global scenario. Nepal J Epidemiol. 2016;6(4):613-619.doi:10.3126/nje.v6i4.17255
36.
HowladerN.NooneA.KrapchoM. SEER Cancer Statistics Review, 1975-2012 [seer. cancer. gov/csr. 1975_2012/, based on the November 2014 SEER data submission, posted to the SEER website April 2015]. Bethesda, MD: National Cancer Institute; 2015.
37.
JonesA.GulbisA.BakerEH. Differences in tobacco use between Canada and the United States. Int J Public Health. 2010;55(3):167-175.doi:10.1007/s00038-009-0101-3
38.
DensonL.JanitzAE.BrameLS.CampbellJE. Oral cavity and oropharyngeal cancer: changing trends in incidence in the United States and Oklahoma. J Okla State Med Assoc. 2016;109(7-8):339-345.
39.
WoodsR.O'ReganEM.KennedyS.MartinC.O'LearyJJ.TimonC. Role of human papillomavirus in oropharyngeal squamous cell carcinoma: a review. World J Clin Cases. 2014;2(6):172-193.doi:10.12998/wjcc.v2.i6.172
40.
World Health Organization. Global Status Report on Alcohol 1999, Country Profiles: Region of the Americas. Geneva: World Health Organization; 1999:124-128.
41.
World Health Organization. Global Status Report on Alcohol 2004, Country Profiles: Canada. Geneva: World Health Organization; 2004.
42.
ReidJ.HammondD. Tobacco use in Canada: patterns and trends, 2012 edition (supplement: tobacco control policies in Canada). Waterloo, ON: Propel Centre for Population Health Impact, University of Waterloo; 2012.
Group USCSW. U.S. Cancer Statistics Data Visualizations Tool. www.cdc.gov/cancer/dataviz. Accessed December 29, 2018.
46.
U.S. Department of Health and Human Services, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Atlanta: U.S. Department of Health and Human Services; 2014.
47.
CorsiDJ.BoyleMH.LearSA.ChowCK.TeoKK.SubramanianSV. Trends in smoking in Canada from 1950 to 2011: progression of the tobacco epidemic according to socioeconomic status and geography. Cancer Causes Control. 2014;25(1):45-57.doi:10.1007/s10552-013-0307-9
48.
HwangE.Johnson-ObasekiS.McDonaldJT.ConnellC.CorstenM. Incidence of head and neck cancer and socioeconomic status in Canada from 1992 to 2007. Oral Oncol. 2013;49(11):1072-1076.doi:10.1016/j.oraloncology.2013.08.002
49.
PurkayasthaM.McMahonAD.GibsonJ.ConwayDI. Trends of oral cavity, oropharyngeal and laryngeal cancer incidence in Scotland (1975-2012) - A socioeconomic perspective. Oral Oncol. 2016;61:70-75.doi:10.1016/j.oraloncology.2016.08.015
50.
Association AL. Cutting Tobacco’s Rural Roots: Tobacco Use in Rural Communities. Chicago: American Lung Association; 2015.
51.
AnantharamanD.Abedi-ArdekaniB.BeachlerDCet al. Geographic heterogeneity in the prevalence of human papillomavirus in head and neck cancer. Int J Cancer. 2017;140(9):1968-1975.doi:10.1002/ijc.30608
52.
CohenN.FedewaS.ChenAY. Epidemiology and demographics of the head and neck cancer population. Oral Maxillofac Surg Clin North Am. 2018;30(4):381-395.doi:10.1016/j.coms.2018.06.001
53.
FarajiF.RettigEM.TsaiH-Let al. The prevalence of human papillomavirus in oropharyngeal cancer is increasing regardless of sex or race, and the influence of sex and race on survival is modified by human papillomavirus tumor status. Cancer. 2019;125(5):761-769.doi:10.1002/cncr.31841
54.
ChaturvediAK.AndersonWF.Lortet-TieulentJet al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol. 2013;31(36):4550-4559.doi:10.1200/JCO.2013.50.3870
55.
FarsiNJ.El-ZeinM.GaiedHet al. Sexual behaviours and head and neck cancer: a systematic review and meta-analysis. Cancer Epidemiol. 2015;39(6):1036-1046.doi:10.1016/j.canep.2015.08.010
56.
HabbousS.ChuKP.LauHet al. Human papillomavirus in oropharyngeal cancer in Canada: analysis of 5 comprehensive cancer centres using multiple imputation. CMAJ. 2017;189(32):E1030-E1040.doi:10.1503/cmaj.161379
57.
ShapiroGK.GuichonJ.KelaherM. Canadian school-based HPV vaccine programs and policy considerations. Vaccine. 2017;35(42):5700-5707.doi:10.1016/j.vaccine.2017.07.079
58.
BirdY.ObidiyaO.MahmoodR.NwankwoC.MorarosJ. Human papillomavirus vaccination uptake in Canada: a systematic review and meta-analysis. Int J Prev Med. 2017;8:71-71.doi:10.4103/ijpvm.IJPVM_49_17
59.
McDonaldJT.Johnson-ObasekiS.HwangE.ConnellC.CorstenM. The relationship between survival and socio-economic status for head and neck cancer in Canada. J Otolaryngol Head Neck Surg. 2014;43:2.doi:10.1186/1916-0216-43-2
60.
GreenbergML.BarrRD.DiMonteB.McLaughlinE.GreenbergC. Childhood cancer registries in Ontario, Canada: lessons learned from a comparison of two registries. Int J Cancer. 2003;105(1):88-91.doi:10.1002/ijc.11004
61.
GuptaS.PoleJD. The validity of pediatric cancer diagnoses in a population-based general cancer registry in Ontario, Canada. BMC Cancer. 2016;16(1):885.doi:10.1186/s12885-016-2931-8
62.
HallS.SchulzeK.GroomeP.MackillopW.HolowatyE. Using cancer registry data for survival studies: the example of the Ontario cancer registry. J Clin Epidemiol. 2006;59(1):67-76.doi:10.1016/j.jclinepi.2005.05.001
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
